What is he best known for?
The fields of study he is best known for:
Carlos Caldas spends much of his time researching Breast cancer, Cancer, Genetics, Cancer research and Internal medicine.
His Breast cancer research includes elements of Human genetics, Bioinformatics and Gene expression profiling.
His Cancer study combines topics from a wide range of disciplines, such as Germline mutation, Hereditary diffuse gastric cancer and Carcinoma.
All of his Genetics and Mutation, Gene, Genome, Human genome and DNA Mutational Analysis investigations are sub-components of the entire Genetics study.
His biological study spans a wide range of topics, including Missense mutation, Carcinogenesis, Tumor suppressor gene, Metastatic breast cancer and Adenocarcinoma.
His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Oncology and Pathology.
His most cited work include:
- Signatures of mutational processes in human cancer (5372 citations)
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups (3323 citations)
- International network of cancer genome projects (1611 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Breast cancer, Internal medicine, Cancer research, Cancer and Oncology.
In his research on the topic of Breast cancer, Molecular biology is strongly related with Gene.
His Internal medicine study frequently draws connections to other fields, such as Gastroenterology.
He has included themes like Carcinogenesis, Cancer cell, Metastatic breast cancer, Transcription factor and PI3K/AKT/mTOR pathway in his Cancer research study.
Cancer is a subfield of Genetics that Carlos Caldas investigates.
The study incorporates disciplines such as Neoadjuvant therapy, Early breast cancer, Proportional hazards model, Epirubicin and Tissue microarray in addition to Oncology.
He most often published in these fields:
- Breast cancer (56.39%)
- Internal medicine (32.63%)
- Cancer research (31.43%)
What were the highlights of his more recent work (between 2018-2021)?
- Breast cancer (56.39%)
- Cancer research (31.43%)
- Internal medicine (32.63%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Breast cancer, Cancer research, Internal medicine, Cancer and Oncology.
His Breast cancer research integrates issues from Chemotherapy, Somatic cell, Germline, Disease and Computational biology.
His Cancer research study incorporates themes from Metastatic breast cancer, Transcription factor, Gene, Exome and PI3K/AKT/mTOR pathway.
His Internal medicine research focuses on Single-nucleotide polymorphism and how it relates to Barrett's esophagus.
The concepts of his Cancer study are interwoven with issues in Phenotype, Clinical trial, Gene knockdown and Mutation.
His Oncology research is multidisciplinary, relying on both Neoadjuvant therapy, Early breast cancer, Immune system, Estrogen receptor and Circulating tumor DNA.
Between 2018 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Caring for patients with cancer in the COVID-19 era. (135 citations)
- 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial (79 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Breast cancer, Cancer research, Cancer, Internal medicine and Oncology.
Carlos Caldas specializes in Breast cancer, namely Estrogen receptor.
His Cancer research research includes themes of Cisplatin, Transcription factor, Gene, Hyperpolarized carbon-13 MRI and In vivo.
His work deals with themes such as Melanoma, Clinical trial, Computational biology and MEDLINE, which intersect with Cancer.
His Hazard ratio, Chemotherapy, Somatic evolution in cancer and Targeted therapy study in the realm of Internal medicine connects with subjects such as Extramural.
His Oncology research includes elements of Triple Negative Breast Neoplasms, Biopsy, Surgical specimen, Primary tumor and Survival analysis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
